This page is part of the FHIR Specification (v4.1.0: Release 4B Ballot #1). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3
Pharmacy Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Encounter, Patient, Practitioner |
Raw JSON (canonical form + also see JSON Format Specification)
Request for Intravenous Chemotherapy (inpatient order) - Brentuximab Vedotin - completed
{ "resourceType": "MedicationRequest", "id": "medrx0316", "text": { "status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><p><b>identifier</b>: id: 12345689 (OFFICIAL)</p><p><b>status</b>: completed</p><p><b>intent</b>: order</p><p><b>medication</b>: <a> </a></p><blockquote><p><b>code</b>: <span>Adcetris</span></p><p><b>form</b>: <span>Lyophilized powder for injectable solution (qualifier value) </span></p><h3>Batches</h3><table><tr><td>-</td><td><b>LotNumber</b></td><td><b>ExpirationDate</b></td></tr><tr><td>*</td><td>12345</td><td>2019-10-31</td></tr></table></blockquote><p><b>subject</b>: <a>Donald Duck. Generated Summary: Medical record number: 654321 (USUAL); active; Duck Donald (OFFICIAL); gender: male</a></p><p><b>encounter</b>: <a>encounter who leads to this prescription. Generated Summary: id: v1451 (OFFICIAL); status: finished; <span>ambulatory</span>; <span>Patient-initiated encounter</span>; <span>Non-urgent cardiological admission</span>; <span>Heart valve replacement</span></a></p><p><b>authoredOn</b>: 2015-01-15</p><p><b>requester</b>: <a>Patrick Pump. Generated Summary: id: 874635264 (OFFICIAL), id: 567IUI51C154 (USUAL); Simone Heps (OFFICIAL); Phone: 020556936, S.M.Heps@bmc.nl, Fax: 0205669283; gender: female; birthDate: 1971-11-07</a></p><p><b>instantiatesUri</b>: <a>http://www.bccancer.bc.ca/chemotherapy-protocols-site/Documents/Lymphoma-Myeloma/ULYBRENTUX%20Protocol_1Jun2017.pdf</a></p><h3>DosageInstructions</h3><table><tr><td>-</td></tr><tr><td>*</td></tr></table></div>" }, "contained": [ { "resourceType": "Medication", "id": "med0306", "code": { "coding": [ { "system": "http://hl7.org/fhir/sid/ndc", "code": "51144-050-01", "display": "Adcetris" } ] }, "form": { "coding": [ { "system": "http://snomed.info/sct", "code": "421637006", "display": "Lyophilized powder for injectable solution (qualifier value) " } ] }, "batch": { "lotNumber": "12345", "expirationDate": "2019-10-31" } } ], "identifier": [ { "use": "official", "system": "http://www.bmc.nl/portal/prescriptions", "value": "12345689" } ], "status": "completed", "intent": "order", "medicationReference": { "reference": "#med0306" }, "subject": { "reference": "Patient/pat1", "display": "Donald Duck" }, "encounter": { "reference": "Encounter/f001", "display": "encounter who leads to this prescription" }, "authoredOn": "2015-01-15", "requester": { "reference": "Practitioner/f007", "display": "Patrick Pump" }, "instantiatesUri": [ "http://www.bccancer.bc.ca/chemotherapy-protocols-site/Documents/Lymphoma-Myeloma/ULYBRENTUX%20Protocol_1Jun2017.pdf" ], "dosageInstruction": [ { "sequence": 1, "text": "1.8 mg/kg IV infusion over 20 minutes every 3 weeks for 16 cycles", "timing": { "repeat": { "count": 16, "frequency": 1, "period": 3, "periodUnit": "wk" } }, "route": { "coding": [ { "system": "http://snomed.info/sct", "code": "255560000", "display": "Intravenous" } ] }, "doseAndRate": [ { "type": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/dose-rate-type", "code": "ordered", "display": "Ordered" } ] }, "doseQuantity": { "value": 1.8, "unit": "mg/kg", "system": "http://unitsofmeasure.org", "code": "mg/kg" }, "rateRatio": { "numerator": { "value": 1.8, "system": "http://unitsofmeasure.org", "code": "mg/kg" }, "denominator": { "value": 20, "system": "http://unitsofmeasure.org", "code": "min" } } } ], "maxDosePerLifetime": { "value": 400, "unit": "mg", "system": "http://unitsofmeasure.org", "code": "mg" } } ] }
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.